Dr. Jennifer Ashley Stableford, MD

Dr. Stableford practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Stableford's NPI, 1316185705, was assigned on January 23, 2009. Dr. Stableford graduated from Loyola University of Chicago, Stritch School of Medicine in 2002. Dr. Stableford holds New Hampshire license 16924.

Dr. Stableford's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Stableford's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Stableford is also affiliated with Alice Peck Day Memorial Hospital. The medical group on file is Dartmouth Hitchcock Clinics Manchester. Dmand AI also links Dr. Stableford to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stableford practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Stableford's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Stableford's licenses on file in 2 states: New Hampshire and New York.

CMS data shows 1,294 Medicare services from Dr. Stableford across 14 procedure codes in 2024, for 1,044 Medicare patients. Medicare paid $37,062 for them.

CMS counts 1,044 Medicare patients who saw Dr. Stableford in 2024. The largest group is 75 to 84, with 413 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stableford's median patient age at 67, with 48% women.

In 2024, Dr. Stableford wrote 122 Medicare Part D claims for 37 patients. 42% of them were for generic drugs. CMS names the drug for 109 of them, across 4 drugs with 11 or more claims each, at $44,098 in total drug cost. In 2023, CMS named 79 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Stableford for performance year 2024, reported through an alternative payment model (APM). Dr. Stableford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of removal of tissue by Dr. Stableford, more than 68% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Stableford, published from 2013 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Regional Blood Flow. Dr. Stableford has published most often in J Vasc Surg. Dr. Stableford's most frequent co-authors are Philip Paul Goodney, MD, Jesse A. Columbo, MD and David H. Stone, MD.

CMS Open Payments shows 23 general payments to Dr. Stableford from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 59% of the total. Silk Road Medical, Inc. paid the most, $1,631.

Dr. Stableford graduated from Loyola University of Chicago, Stritch School of Medicine in 2002.